Bank Of America Corp Ampio Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.08 - $21.0 $74 - $19,656	936 Added 22.3%	5,133 $0
Q2 2022 Aug 12, 2022	SELL	$0.16 - $0.47 $657 - $1,930	-4,108 Reduced 49.46%	4,197 $0
Q1 2022 May 16, 2022	SELL	$0.42 - $0.62 $21,412 - $31,608	-50,982 Reduced 85.99%	8,305 $4,000
Q4 2021 Feb 08, 2022	BUY	$0.56 - $1.71 $30,408 - $92,854	54,301 Added 1089.07%	59,287 $34,000
Q3 2021 Nov 15, 2021	BUY	$1.21 - $1.8 $642 - $955	531 Added 11.92%	4,986 $8,000
Q2 2021 Sep 13, 2021	BUY	$1.56 - $1.98 $6,949 - $8,820	4,455 New	4,455 $7,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.